Lv711
3270 积分 2022-09-02 加入
Ultra low dose radiotherapy for primary ocular adnexal marginal zone lymphoma
13小时前
已完结
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma
13小时前
已完结
Radiation Therapy Dose for Limited-Stage Extranodal Marginal Zone Lymphomas of the Mucosa-Associated Lymphoid Tissues of the Stomach: A Meta-Analysis
13小时前
已完结
Optimizing Palliative Radiation Therapy for Primary Cutaneous B-Cell Lymphoma: Is Ultra-Low Dose (4 Gy) Enough?
13小时前
已关闭
Real-World Outcomes with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective Study
1天前
已完结
Autoimmune haemolytic anaemias
9天前
已完结
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study
13天前
已完结
A monocentric retrospective study comparing pulse cyclophosphamide therapy versus low dose rituximab in the treatment of refractory autoimmune hemolytic anemia in adults
15天前
已关闭
Long‐lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B‐cell lymphoma who are not eligible for or failed autologous transplantation
22天前
已完结
Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Long-term results of the HOVON-84 randomized phase III study by the HOVON and the Nordic Lymphoma Group (clinical trial number: NTR1014)
22天前
已完结
皖公网安备34019202002308
